01 / OVERVIEW
What it is
PT-141 (bremelanotide) is a peptide that activates melanocortin receptors in the brain. It was FDA-approved in 2019 to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.
GET STARTEDPEPTIDE THERAPY / SEXUAL HEALTH
Bremelanotide
A peptide that works in the brain to increase sexual desire, rather than acting on blood flow.
KEY TAKEAWAYS
01 / OVERVIEW
PT-141 (bremelanotide) is a peptide that activates melanocortin receptors in the brain. It was FDA-approved in 2019 to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.
02 / MECHANISM
Rather than increasing blood flow, bremelanotide is thought to influence the brain pathways involved in sexual desire and arousal. It is used on demand before anticipated sexual activity.
03 / EVIDENCE
In two phase 3 trials (RECONNECT), premenopausal women with HSDD who used bremelanotide reported modest but statistically significant improvements in desire and reduced distress compared with placebo. Use in men and postmenopausal women has been studied less and is considered off-label.
04 / FIT
05 / CAUTION
06 / SAFETY
This is not a complete list. Your provider will review risks, benefits, and alternatives with you before starting any treatment.
QUESTIONS
No. Medications like sildenafil act on blood flow; PT-141 works in the brain on desire.
Use is limited and as needed. Your provider will explain safe use for your situation.
Use in men is off-label and less studied. Your provider can discuss whether it may be appropriate.
Complete a short Get Started form. A licensed provider in your state will review your goals and history by telehealth, order labs if needed, and decide whether PT-141 or another option is appropriate.
KEEP LEARNING
A naturally occurring hormone involved in bonding, intimacy, and sexual response.
A peptide that encourages your pituitary gland to release more of your own growth hormone.
A coenzyme found in every cell that supports energy production and cellular repair, and declines with age.
This page is for general education and is not medical advice. PT-141 requires a prescription and is provided only after evaluation by a licensed provider when appropriate. When a compounded formulation is prescribed, it is prepared by a licensed U.S. pharmacy for you specifically. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.